BioLineRx Ltd.

BLRX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 24 employees
432
SEC Filings
$3.03
Close 2026-07-09
24
Employees

Business Summary

BioLineRx Ltd. is an Israeli biopharmaceutical company focused on oncology and rare diseases. Its first approved product is APHEXDA (motixafortide), an FDA-approved peptide for hematopoietic stem cell mobilization in multiple myeloma patients. The company has out-licensed motixafortide rights to partners in Asia and globally, and in September 2025 entered a collaboration with Hemispherian to develop GLIX1, a first-in-class oral small molecule targeting DNA damage response in glioblastoma and other solid tumors.

Latest Stock Quote

BLRX 2026-07-09 $3.03 O:$3 H:$3.03 L:$2.83 Vol:0.0M VWAP:$2.9679
origin leaf: null

432 total filings indexed. 432 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

oncology rare-diseases hematopoietic-stem-cell-mobilization glioblastoma

Company Identity

CIK0001498403
TickerBLRX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedL3
Websitehttps://www.biolinerx.com
Listed2011-07-25

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: ecc85809a5b16cfbfc728f587ed7eb880a57efdbf47865a822fd9b6464d35043
parent: root
content hash: 425e9062233eb3b67838b1daca6b7c7de529c815a3b2b242a233ff6816f1e62d
signed: 2026-08-13T19:01:25.436Z
sources: 0 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up BLRX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on BLRX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/BLRX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.